Manufacturing

Pharma Manufacturing practices include all methods that are required to develop Pharma services. These practices provide minimum requirements that must and should be met by pharmaceutical companies in order to provide high-quality products that will pose no risk to the patients/consumers at large. Pharmaceutical contract manufacturing process involves Pharmaceutical machinery, drug manufacturers contracting a firm for finished products or components. It can be seen as a type of outsourcing. Organizations succeed by focusing on what they do best to their consumers, partners or outsourced vendors. Contract manufacturing seems to fit neatly into this scenario.

Trends in Pharmaceutical Packaging and Delivery

..

Immunogenicity of Protein Biotherapeutics and Methods for Assessment of Immunogenicity

All protein biotherapeutics are potentially immunogenic and hence could elicit immunogenicity response These responses could be of different types such as binding antibodies or neutralising antibodies Immunogenicity of protein biotherapeutics is a major concern especially when the biological functio..

Towards the Operationalisation of Production Systems

Simultaneously increasing effectiveness and efficiency

In recent history Multinational Corporations MNCs from all industries have established their own production systems based on Toyotas unique success story Nevertheless industrial companies are still facing issues when it comes to the quantification of the influence of single system elements on the co..

Innovation Challenges in Manufacturing

Most firms in the pharmaceutical industry think globally to expand demand for their products There are amenities from which firms leverage to launch a strategy to gain global market share These amenities include the regulatory dimension which helps reassign resources within and outside the firm..

Modularisation in Biologics Manufacturing

Recent trends and developments

The inherent risk in establishing biopharmaceutical production product process timeline capacity regulatory and location can be significantly mitigated by using a modular and standardised approach Utilising a combination of standardisation modularisation and use of modern process solutions such as s..

Antibody Drug Conjugates in Reducing Disease Burden

Immense Promise with Some Challenges

Antibody Drug Conjugates provide a high level of promise and hence there will be a conscious effort to expand the applications of this technology to disease indications beyond oncology provide a high level of promise and hence there will be a conscious effort to expand the applications of this techn..

Unlocking the value

PLM solution in packaging and labelling

The pharma industry can add value reduce costs and improve the overall quality of its products by improving packaging and labelling processes enabled by integrated Product Lifecycle Management solutions..

Using Chemometrics in PAT

Investigating data from the process

Processes of today are often equipped with sensors and measurement systems collecting large amount of data Chemometrics is developed to handle large amount of data for overview monitoring and relations between raw materials process parameters instruments and Critical Quality Attributes..

Eliminating Guesswork

Automating PAT PM process control

Modern process analytical technology systems generate continuous quality monitoring and provide plant process controllers with highly useful process information to increase the productivity and adhere to higher quality standards..

Large-scale Biochromatography

What lies ahead?

Many new approaches have been considered for largescale chromatography including membrane adsorbers The benefits and drawbacks of these devices and their potential impact on the biopharmaceutical industry are discussed..

TOP